FORA Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

FORA Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	+5,408	New	+$1.18M	0.09%	198
2023 Q4	–	Sell	-9,909	Closed	-$1.28M	–	532
2023 Q3	$1.28M	Sell	9,909 -6,783	-41%	-$904K	0.11%	213
2023 Q2	$2.07M	Buy	16,692 +7,073	+74%	+$952K	0.29%	96
2023 Q1	$1.41M	Buy	+9,619	New	+$1.42M	0.14%	201
2022 Q3	–	Sell	-1,433	Closed	-$224K	–	484
2022 Q2	$224K	Buy	+1,433	New	+$221K	0.04%	381
2021 Q3	–	Sell	-251	Closed	-$45K	–	608
2021 Q2	$45K	Buy	+251	New	+$43.5K	0.01%	729
2020 Q2	–	Sell	-3,554	Closed	-$354K	–	1102
2020 Q1	$354K	Buy	3,554 +1,012	+40%	+$131K	0.08%	311
2019 Q4	$379K	Buy	+2,542	New	+$346K	0.04%	464

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

FORA Capital's JAZZ Position: Q2 2026 in Review

FORA Capital opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 5,408 shares worth $1.3M. The stake represents 0.09% of the portfolio and ranks #198 among its holdings. This is a return to the name: FORA Capital previously reported a position in JAZZ as recently as Q3 2023.

FORA Capital first reported a position in JAZZ in Q4 2019 and has held it in 8 quarters since. The position peaked at $2.07M in Q2 2023. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

FORA Capital held 5,408 shares of Jazz Pharmaceuticals worth $1.3M as of Q2 2026.
Jazz Pharmaceuticals was a new FORA Capital position in Q2 2026.
Jazz Pharmaceuticals made up 0.09% of FORA Capital's portfolio in Q2 2026, its #198 holding.
FORA Capital first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 8 quarters since.
FORA Capital's Jazz Pharmaceuticals position peaked at $2.07M in Q2 2023.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.